申请人:DAIICHI SANKYO COMPANY, LIMITED
公开号:US20170107207A1
公开(公告)日:2017-04-20
The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which has an excellent inhibitory action on the ATPase activity of a TIP48/TIP49 complex and as such, is useful for the treatment of tumors.
[Solution]
The present invention provides a compound having a structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, and W are as defined in the present specification.